Analysing the Shift in Prescribing Patterns: Sodium Glucose Co-transporter 2 Inhibitors, Dipeptidyl Peptidase 4 Inhibitors and Traditional Antidiabetic Drugs.
| dc.contributor.author | Pavithran, V | en_US |
| dc.contributor.author | Balachandran, P | en_US |
| dc.contributor.author | Sajeeth, CI | en_US |
| dc.contributor.author | Hariharan, A | en_US |
| dc.date.accessioned | 2025-08-13T10:00:10Z | |
| dc.date.available | 2025-08-13T10:00:10Z | |
| dc.date.issued | 2025-03 | |
| dc.description.abstract | Abstract: India currently has around 77 million adults living with diabetes. Considering the growing impact of diabetesrelated complications, we aimed to compare the real-world prescribing patterns of sodium-glucose cotransporter-2 inhibitors, dipeptidyl peptidase-4 inhibitors and traditional antidiabetics. Using a cross-sectional study design, the prescribing pattern and factors influencing the utilisation of the antidiabetic drugs, categorised by the HbA1c status, were assessed using the chi-square test. Of 260 eligible adults with mean [SD] age, 63.7[12.4] years; 54.7% of male participants initiated treatment with sodium-glucose cotransporter-2 inhibitors (n=27) or a dipeptidyl peptidase-4 inhibitors (n=31). The use of newer antidiabetic agents has steadily increased, with a slightly higher initiation rate in those over 65 years (21.5%). No significant difference was observed based on age (p = 0.182) or gender (p = 0.9548). Prescriber speciality had a significant impact (p = 0.00038). Cardiologists showed the highest shift towards newer drugs (36.5%). Prescriptions of newer antidiabetics have shown an upward trend over time, indicating a shift in prescribing practices. However, this increase was limited. Further efforts are necessary to identify and address the barriers to underutilisation of these drugs | en_US |
| dc.identifier.affiliations | Research Scholar, Department of Pharmacy, Annamalai University, Annamalai Nagar, Tamil Nadu, India - 608002 | en_US |
| dc.identifier.affiliations | Assistant Professor, Department of Pharmacy, Annamalai University, Annamalai Nagar, Tamil Nadu, India - 608002 | en_US |
| dc.identifier.affiliations | Professor and HOD, Department of Pharmacy, Grace college of Pharmacy, Palakkad, Kerala, India - 678004 | en_US |
| dc.identifier.affiliations | Assistant Professor, Department of General Medicine, Karuna Medical College and Hospital, Palakkad, Kerala, India - 678103 | en_US |
| dc.identifier.citation | Pavithran V, Balachandran P, Sajeeth CI, Hariharan A. Analysing the Shift in Prescribing Patterns: Sodium Glucose Co-transporter 2 Inhibitors, Dipeptidyl Peptidase 4 Inhibitors and Traditional Antidiabetic Drugs.. Online Journal of Health and Allied Sciences. 2025 Mar; 24(93): 1-6 | en_US |
| dc.identifier.issn | 0972-5997 | |
| dc.identifier.place | India | en_US |
| dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/252878 | |
| dc.language | en | en_US |
| dc.publisher | Light House Polyclinic | en_US |
| dc.relation.issuenumber | 93 | en_US |
| dc.relation.volume | 24 | en_US |
| dc.source.uri | https://www.ojhas.org/issue93/2025-1-5.pdf | en_US |
| dc.subject | Dipeptidyl peptidase inhibitors | en_US |
| dc.subject | HbA1c | en_US |
| dc.subject | Prescribing pattern | en_US |
| dc.subject | Sodium glucose cotransporter 2 inhibitors | en_US |
| dc.subject | Type 2 Diabetes Mellitus. | en_US |
| dc.title | Analysing the Shift in Prescribing Patterns: Sodium Glucose Co-transporter 2 Inhibitors, Dipeptidyl Peptidase 4 Inhibitors and Traditional Antidiabetic Drugs. | en_US |
| dc.type | Journal Article | en_US |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- ojhas2025v24n93p1d.pdf
- Size:
- 316.22 KB
- Format:
- Adobe Portable Document Format